Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 102 | EYES2024

ESE Young Endocrinologists and Scientists (EYES) 2024

ea010288 | Reproductive Endocrinology | EYES2024

Induction of spermatogenesis in men with hypogonadotropic hypogonadism

Boskovic Andjela , Ivovic Miomira , Tancic Gajic Milina , Marina Ljiljana , Pantovic Veljko , Jovanovic Milica , Pavlovic Natalija , Arizanovic Zorana , Bojovic Taisa , Vujovic Svetlana

Introduction: Hypogonadotropic hypogonadism (HH) is a type of secondary hypogonadism. Congenital forms are distinguished, including Kallman's syndrome and Idiopathic hypogonadotropic hypogonadism (IHH), along with acquired forms. The incidence of HH in men is 1:10,000.Case report: A 34-year-old male patient was hospitalized at our department in August 2023 due to primary infertility and sexual dysfunction (SD). The patient was referred to our cli...

ea010223 | Reproductive Endocrinology | EYES2024

Previous illicit androgen users display persistently impaired Leydig cell capacity but recovered luteinising hormone secretion

Bulut Yeliz , Brandt-Jacobsen Niels , Madsen Rasmus , Frystyk Jan , Albrethsen Jakob , Jorgensen Niels , Juul Anders , Kistorp Caroline , Jarlov Rasmussen Jon

Background: A general finding among previous illicit androgen male users is persistently lower serum testosterone than nonusers and may be caused by reduced pituitary luteinising hormone (LH) secretion. However, the functional capacity of the testes and pituitary remains to be assessed after androgen use. We compared pituitary-testis-axis capacity in previous illicit androgen users and nonusers.Methods: We conducted a cross-sectional study including men ...

ea010250 | Reproductive Endocrinology | EYES2024

Variations in the assessment and education of polycystic ovary syndrome (PCOS) during initial consultations across europe and india: a multinational study

Chu Agatha , Davitadze Meri , Arshad Amynta , Khan Sahrish , Wilde Alexander , James Angharad , Palani Raghavendar , Abdullayeva Elmira , Lafara Kyranna , Mintziori Gesthimani , SEva Working Group PCOS

Introduction: Women with polycystic ovary syndrome (PCOS) are often dissatisfied with the assessment and management of the condition. We aimed to understand the variations in the assessment and education of PCOS during initial consultations.Methods: This retrospective multinational study was conducted across Europe and India. All women aged above 18 who had their initial consultation in PCOS clinics between 2020 and 2023 were included. Those without PCOS...

ea010228 | Reproductive Endocrinology | EYES2024

Testosterone serum levels predict the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in hypogonadal men

Dalla Valentina Leonardo , Spaggiari Giorgia , Nascimbeni Fabio , Lugari Simonetta , Feliciani Cristina , Ahmad Ali , R. M. Granata Antonio , Andreone Pietro , Simoni Manuela , Santi Daniele

Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by the presence of hepatic steatosis and metabolic risk factors. Both testosterone and estradiol play pivotal roles in hepatic lipid homeostasis, though the underlying mechanisms remain unclear. Low serum testosterone levels are independently associated with MASLD. However, no studies have previously evaluated the prevalence and severity of MASLD in hypogonadal men. <p class="abstext"...

ea010275 | Reproductive Endocrinology | EYES2024

Tamoxifen use in gynecomastia: a tertiary centre experience

Monteiro Antunes Carolina , Guia Lopes Leonor , Calvo Paula , Oliveira Margarida , Gama Catarina , Pimentel Bruna , Sousa Santos Francisco , Sequeira Duarte Joao

Introduction: Gynecomastia is defined as the benign proliferation of breast tissue in men. Although common, only a small portion of patients seek treatment, either for cosmetic reasons, pain, or tenderness. Tamoxifen has been proposed as an alternative to surgical treatment. Methods : We conducted a retrospective study including all patients referred to our Endocrinology Department between January 2020 and April 2024 due to gynecomastia. Secondary causes...

ea010271 | Reproductive Endocrinology | EYES2024

Copy number variations in self-limited delayed puberty

Al-Sayed Yasmin , Hall Charlotte , Ishida Miho , Howard Sasha

SLDP is where the onset of puberty is more than 2-2.5 standard deviations later than the population mean age and is often familial with strong genetic determinants. The reproductive axis is regulated by gonadotropin-releasing hormone (GnRH), which plays a crucial role in initiating puberty and maintaining fertility through its pulsatile secretion. Disruption in GnRH neuron development or hypothalamic function can lead to DP. UK Biobank data has identified negative health outco...

ea0102100 | Reproductive Endocrinology | EYES2024

Short-term changes in bone metabolism among transgender men starting gender affirming hormone therapy: a systematic review and meta-analysis

Marinelli Lorenzo , Tienforti Daniele , Vervalcke Jeroen , Bichiri Andreina , T'Sjoen Guy , Motta Giovanna , Barbonetti Arcangelo

Introduction: Transgender and gender diverse (TGD) people experience a gender identity which is different from the sex assigned at birth. Some transgender men (TM) can ask for testosterone to induce virilization and its effects on bone health are still to be fully elucidated. The aim of this systematic review and meta-analysis was to evaluate the changes on bone metabolism in a short-term period among TM starting testosterone. Methods: A systematic searc...

ea010240 | Reproductive Endocrinology | EYES2024

Tyrosine kinase inhibitors: systematic review of their effects on male gonadal function

Marino Marta , Cannarella Rossella , Condorelli Rosita A. , Crafa Andrea , La Vignera Sandro , E. Calogero Aldo

Introduction: Tumors in adolescents and young adults are on the rise, and the number of young cancer patients undergoing chronic treatment with targeted therapy is growing. Although much is known about the toxicity of conventional anti-cancer therapies, evidence on tyrosine kinase inhibitor (TKI) effects on fertility is still lacking. This systematic review was undertaken to evaluate the effects of TKIs on male gonadal function to provide adequate counseling to patients underg...

ea010254 | Reproductive Endocrinology | EYES2024

Is menopause the answer for a 47 year old woman?

Neacşu Andra

Introduction: Functional hypothalamic amenorrhea is one of the most common causes of secondary amenorrhea (20–35%) and 3% of primary amenorrhea. FHA can be weight loss-related, stress-related and exercise-related. It results from abnormal GnRH secretion, leading to impairment of gonadotropins and hypoestrogenism.Case presentation: A 47 year-old female presents for an endocrine evaluation regarding hormone function after 2 years of amenorrhea. She al...

ea010268 | Reproductive Endocrinology | EYES2024

Anogenital distance in klinefelter syndrome: a case-control study

Vitale Valentina , Vena Walter , Bughetti Chiara , Brunetti Alessandro , Maida Giulia , Morenghi Emanuela , Negri Luciano , Benaglia Renzo , Bossi Antonio , Vescini Fabio , Mazziotti Gherardo , Lania Andrea , Pizzocaro Alessandro

Background: Serum testosterone (T) levels may fall at different stages of sexual development in Klinefelter syndrome (KS), whereas overt hypogonadism typically arises after puberty. Nevertheless, normal mini-puberty and puberty are still debated in KS subjects. Anogenital distance (AGD) is an anthropometric parameter under the influence of early life and childhood androgen exposure. Genital anomalies, testicular cancer and oligospermia have been associated with a shorter AGD i...